The science behind the platform: two decades of peer-reviewed laser-assisted bioprinting research, from foundational physics to clinical-grade manufacturing.
One platform that grows with your science. The NGB-R® combines a laser source, a 6-axis robotic arm, and interchangeable heads and modules, each engineered for a step of the biofabrication workflow.
Upgrade and complete when you need. Multiple print heads, broad bio-ink compatibility, a fully automated workflow.
In-line microscope resolution
6-axis arm accuracy
Laser droplet deposition
The same platform, laid out as the printed system overview. Select a point on the machine, or a subsystem, to highlight it.
Built on the same architecture, the NGB-R® and NGB-C® ensure a seamless path from research to clinical translation.
Explore a wide range of biofabrication strategies to improve the accuracy and reproducibility of your 3D culture models.
Discover NGB-R® →
The first clinical-grade, GMP-compliant bioprinter. A seamless continuum from research to clinical translation, ready for ATMP.
Discover NGB-C® →The platform is engineered around the four challenges of 3D bioprinting.
Laser-Assisted Bioprinting (LAB) is based on laser-induced forward transfer. A pulsed laser propels picoliter droplets from a donor slide to the receiver, with zero mechanical contact.
No constricted channel means no shear damage. Cells are deposited intact, at high viability and high resolution.
Alternatives look cheaper to buy. At industrial scale, and for medical applications, laser precision lowers the real cost of use.
Faithfully reproduce the 3D architecture and multicellular interactions that govern tissue function in vivo, across oncology, drug testing, and regenerative medicine.
Autologous full-thickness skin substitute, 40 cm², manufactured under GMP-compatible conditions. Phase I/IIa trial in progress at AP-HM, Marseille.
Stem cells, cells, organoids, hydrogels.
3D models, organs-on-chips, tissue constructs.
The platform is built on the published work of Poietis founder Fabien Guillemot and the laser-bioprinting field he helped establish at the University of Bordeaux. The underlying science is protected by a growing patent portfolio across Europe, the United States, China, Korea, and Japan.
Poietis Biosystems collaborates with leading universities, research institutes, and hospitals across Europe and beyond.
Clinical translation with AP-HM, Marseille. Scientific collaborations including MERLN Institute, Harvard, Northeastern, and Washington University.
Poietis pioneered Laser-Assisted Bioprinting and has advanced high-resolution, cell-level deposition since 2014. Our engineers, biologists, and software builders turn that science - peer-reviewed and protected by 100+ patents across Europe, the United States, China, Korea, and Japan - into reliable NGB instruments, from the research bench to GMP manufacturing.
Your projects. Your discoveries. Your regulatory ambition. Discover how the NGB platform accelerates biofabrication from your first prototype to clinical-grade manufacturing.
